Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 14 of 14 for “"Ascvd"”.
-
Improving Equity In Atherosclerotic Cardiovascular Disease Risk
… in Atherosclerotic Cardiovascular Disease (ASCVD) risk, limits assessment of confounders beyond cholesterol. The Life’s Essential Eight (LE8) categories of healthy diet, sleep, physical activity, smoking, body mass index, hypertension, total cholesterol, and blood glucose could reduce two …
-
Improving Estimation of Coronary Artery Disease Risk Using Haptoglobin Genotyping
<p>Atherosclerotic cardiovascular disease (ASCVD) continues to be the leading cause of death worldwide. While several risk factors contributing to disease progression are well-known, pitfalls and limitations exist for estimating if or when an individual will develop the disease. Coronary artery …
-
ATHEROSCLEROSIS AND ENDOTHELIAL DYSFUNCTION IN THALASSEMIA
… on atherosclerotic cardiovascular disease (ASCVD) underline the importance of screening every person for ASCVD risk factors to better prevent the disease. However, only a few small studies evaluated the prevalence of ASCVD and its risk factors in thalassemia patients, and the majority are …
-
CORONARY ARTERY CALCIUM SCORES FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK STRATIFICATION IN SMOKERS: MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS
… CAC for atherosclerotic cardiovascular disease (ASCVD) risk stratification remains unclear in this high-risk group. We assess this potential in smokers, especially those eligible for LDCT lung cancer screening.
-
Association of blood lipids, atherosclerosis and statin use with dementia after stroke
… prior atherosclerotic cardiovascular disease (ASCVD) were more likely to develop subsequent dementia (aHR 1.18, 95% CI 1.12-1.25). After full adjustment for potential baseline confounding, however, the risk of post-stroke dementia is attenuated (aHR 1.07, 95% CI 1.00-1.13), with no linear …
-
Molecular Mediators of Macrophage Foam Cell Formation and Atherosclerosis and their Pharmacological Modification
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and morbidity around the world. It results from build-up of cholesterol-rich, inflamed plaques in the walls of arteries. Inflammation is central to atherosclerosis. A key driver of inflammation in plaque is the accumulation …
-
The effect of social isolation, loneliness, and low social support on cardiovascular events
… atherosclerotic cardiovascular disease (ASCVD), at risk of developing cardiovascular events (CVEs), if exposed to social isolation, loneliness, or low social support? PICO elements: The population (adult cohort with no pre-existing ASCVD conditions). Exposure (social isolation and/or low …
-
The use of bempedoic acid in treating hypercholesterolemia
… of atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) or both. Based on promising results from phase III clinical trials, the Food and Drug Administration (FDA) approved bempedoic acid, under the brand name Nexletol, for treatment of …
-
Association Of Kidney Stones With Chronic Disease Among Adults In The United States: Considerations By Race-Ethnicity
… equations to predict 10-yr risk of a future ASCVD event, kidney stones was only associated with future risk among non-Hispanic black kidney stone formers
-
Βιβλιογραφική ανασκόπηση κλινικών μελετών που εξετάζουν το ρόλο της λιποπρωτεΐνης α (Lpa) στην καρδιαγγειακή νόσο / The role of lipoprotein (a) in cardiovascular disease: a literature review of clinical evidence
… (Atherosclerotic Cardiovascular Disease - ASCVD) σε πληθυσμούς πρωτογενούς και δευτερογενούς πρόληψης υψηλού κινδύνου παραμένει ασαφής. Υπό αυτό το πρίσμα, πραγματοποιήθηκε βιβλιογραφική ανασκόπηση προοπτικών μελετών για τη διερεύνηση της σχέσης μεταξύ των αποτελεσμάτων της Lp(a) και CVD …
-
USE OF MULTIPLE ANALYTIC APPROACHES TO IDENTIFY NEW MARKERS/RISK FACTORS FOR CARDIOVASCULAR DISEASES AND EVALUATE THEIR ROLE AS POSSIBLE PHARMACOLOGICAL TARGETS
La malattia cardiovascolare aterosclerotica (ASCVD) è una delle principali cause di morbilità e mortalità a livello mondiale. Gli elevati livelli di colesterolo delle lipoproteine a bassa densità (LDL-C) sono un importante fattore di rischio modificabile. Sebbene siano disponibili diverse …
-
Relación entre NETs, microbiota intestinal y translocación bacteriana en pacientes infectados por VIH y en un modelo animal con depleción de BATF
… incluidos en las escalas REGICOR y ASCVD. Se estudió la existencia de aterosclerosis subclínica, detectada mediante ecografía Doppler carotídea, así como el efecto sobre los parámetros mencionados de la TAR, la adherencia a la dieta mediterránea (evaluada mediante un cuestionario de …
-
From Theory to Practice: Improving Causal Conclusions from Healthcare Data
… use and atherosclerotic cardiovascular disease (ASCVD) incidence, we examine how including extraneous covariates---a likely risk when researchers over-adjust to mitigate concerns about unmeasured confounding---may degrade estimator performance. These findings highlight the importance of …
-
UNVEILING THE ADVERSE EFFECTS OF POLYSTYRENE NANOPLASTICS IN THE HUMAN-DERIVED HEPG2-OA STEATOTIC-LIKE MODEL, VALIDATING DYSFUNCTIONAL HUMAN-DERIVED SW872 ADIPOCYTE IN VITRO MODELS FOR THE STUDY OF CARDIOMETABOLIC DISEASES, AND ASSESSING TRIMETHYLAMINE N-OXIDE IN A PLIC STUDY SUB-COHORT
… della malattia cardiovascolare aterosclerotica (ASCVD) sulla base di studi condotti utilizzando modelli in vitro e in vivo, a seguito di innalzamento dei livelli circolanti di TMAO in presenza di disbiosi intestinale e compromissione renale o in base al consumo di determinati alimenti. Studi di …